Eplerenone administration has beneficial effect on hepatic paraoxonase 1 activity in diabetic mice

Atherosclerosis. 2010 Jan;208(1):26-7. doi: 10.1016/j.atherosclerosis.2009.06.038. Epub 2009 Jul 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Aryldialkylphosphatase / metabolism*
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / enzymology*
  • Eplerenone
  • Mice
  • Spironolactone / analogs & derivatives*
  • Spironolactone / therapeutic use

Substances

  • Spironolactone
  • Eplerenone
  • Aryldialkylphosphatase